Source: Eur Respir J 2010; 36: 1242-1247
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Sester M., Giehl C., McNerney R., Kampmann B., Walzl G., Cuchí P., Wingfield C., Lange C., Migliori G.B., Kritski A.L., Meyerhans A.. Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection. Eur Respir J 2010; 36: 1242-1247

Member's Comments

No comment yet.

Related content which might interest you: Clinical management of tuberculosis and HIV-1 co-infection Source: Eur Respir J 2010; 36: 1460-1481 Year: 2010 HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Molecular surveillance of multi-drug resistant tuberculosis in Europe Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 The incidence of MDR-TB in new and retreatment cases of HIV and pulmonary tuberculosis co-infection Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results Source: Eur Respir J 2011; 38: 1374-1381 Year: 2011 TB drug resistance in high-incidence countries Source: Eur Respir Mon 2012; 58: 95-110 Year: 2012 Experience in the use of Bedakville in the therapy of multidrug-resistant tuberculosis and HIV infection. Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018 Strategies against multidrug-resistant tuberculosis Source: Eur Respir J 2002; 20: 66S-77S Year: 2002 TB situation in Bulgaria – epidemiology, TB-HIV co-infection Source: Eur Respir J 2006; 28: Suppl. 50, 16s Year: 2006 TB in children Source: Eur Respir Mon 2012; 58: 206-218 Year: 2012 The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis Source: Eur Respir J 2012; 39: 626-634 Year: 2012 Pre-immigration screening process and pulmonary tuberculosis among Ethiopian migrants in Israel Source: Eur Respir J 2008; 32: 413-418 Year: 2008 Current status of fluoroquinolone use for treatment of tuberculosis in Korea Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy Source: Eur Respir J 2004; 24: 11-17 Year: 2004 Treatment outcomes of MDR-TB and HIV co-infection in Europe Source: Eur Respir J, 49 (6) 1602363; 10.1183/13993003.02363-2016 Year: 2017 European framework to decrease the burden of TB/HIV Source: Eur Respir J 2004; 24: 493-501 Year: 2004 High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons Source: International Congress 2015 – Screening strategies in TB Year: 2015 Tuberculosis and HIV co-infection: do we have a surveillance system in Europe? Source: Eur Respir J 2011; 38: 1258-1260 Year: 2011 TB in migrants Source: Eur Respir Mon 2012; 58: 194-205 Year: 2012